📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Modelling the Interaction between Danoprevir and Mericitabine in the Treatment of Chronic HCV Infection (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3851/imp3006

PubMed Identifier: 26555159

Publication URI: http://europepmc.org/abstract/MED/26555159

Type: Journal Article/Review

Parent Publication: Antiviral Therapy

Issue: 4

ISSN: 20402058 13596535